The ICH E6(R3) Guideline: A Major Update to Good Clinical Practice
FDA Law Blog
FEBRUARY 27, 2025
E6(R3) specifically acknowledges the rise of innovative trial designs such as adaptive and decentralized methods, while also encouraging the use of electronic informed consent and remote monitoring.
Let's personalize your content